Clostridioides difficile infection (CDI) is a serious gastrointestinal disease, often caused by inappropriate antimicrobial use.
Found 89 result(s)
The Commission develops courses that provide an overview of National Safety and Quality Standards and assessment under the rules of the Australian Health Service Safety and Quality Accreditation (AHSSQA) Scheme.
The primary care sector has an important role to play in improving the safe and appropriate use of antimicrobials, and reducing patient harm and the risk of antimicrobial resistance (AMR) in Australia.
These FAQs answer some common questions about the Comprehensive Care Standard, and more generally what comprehensive care means in the Australian health system.
The Commonwealth, state and territory governments across Australia are increasing their focus on improving the safety and quality of end-of-life care.
Effective infection prevention and control practices reduce the risk of transmission of infections between patients, healthcare workers and others in the healthcare environment.
Comprehensive care at the end of life
Comprehensive care at the end of life
Information and decision support tools for medicines
Adverse drug reactions
Medication reconciliation
Safety and quality training
By working in partnership with the Australian Government, states and territories, the private sector, clinical experts, and patients and carers, the Australian Commission on Safety and Quality in Health Care aims to ensure that the health system is better informed, supported and organised to deliver safe and high-quality care.
Surgical antimicrobial prophylaxis is the use of antimicrobials to prevent infections that may occur as a result of a surgical procedure. This page provides information on the appropriateness of this prescribing.
This page includes links to Australian and international resources to support antimicrobial stewardship (AMS) programs in health service organisations and in aged care and primary care. AMS programs help to improve patient safety and in the prevention and control of antimicrobial resistance (AMR).
Antimicrobial Stewardship in Australian Health Care (the AMS Book), initially published in 2018, continues to be updated and enhanced with additional evidence, information, and topic areas to inform antimicrobial stewardship (AMS) strategies, interventions, and implementation across a range of healthcare settings.
High risk medicines (HRMs) are medications that have an increased risk of causing significant patient harm or death if they are misused or used in error.1
The rate of Staphylococcus aureus bloodstream infection (SABSI) in a hospital is considered to be an indication of the effectiveness of the hospital’s infection prevention and control program.
This page includes information on infection prevention and control (IPC) strategies for carbapenemase-producing organisms (CPOs) and links to additional resources.